Arca
Skip to content

hearOAE

Audiometer. 510(k) K231545, from Hearx SA (Pty) , Ltd. (Pretoria, ZA). Product code EWO, class 2.

As of Nov 17, 2026, K231545 is an FDA 510(k) held by Hearx SA (Pty) , Ltd., substantially equivalent on Oct 27, 2023 after 150 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Oct 27, 2023
  • Review time: 150 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

hearOAE is intended to be used by hearing healthcare professionals in the audiologic evaluation and documentation of ear function and ear disorders using Transient Evoked Otoacoustic Emissions (TEOAEs) and Distortion Product Otoacoustic Emissions (DPOAEs). The target population for the hearOAE includes all ages.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other EWO Clearances

The newest 510(k)s for the same product code; their median review was 178 days; see every EWO device

Record

Type
Traditional
Received
May 30, 2023
Review panel
Ear, Nose, Throat
Regulation
21 CFR 874.1050

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.